Riga Stradins University

University

2 profile visits

About

The Institute of Microbiology and Virology (MVI) at Rīga Stradiņš University (RSU), Latvia, is a multidisciplinary research institute with strong expertise in medical microbiology, virology, molecular biology, immunology, and host–pathogen interactions. Its research spans infectious diseases, cancer immunology, autoimmune disorders, and post-infectious chronic diseases, including ME/CFS and Long COVID. Equipped with advanced molecular and cellular research infrastructure, the institute integrates fundamental research, clinical investigations, and innovative diagnostic and therapeutic approaches. Through extensive international collaborations, competitive research programmes, and industry partnerships, MVI fosters scientific excellence, translational innovation, and the training of next-generation researchers.

Social media

Representatives

Tenured Professor

Riga Stradins University

Clinical Nurse Researcher, Lecturer & PhD Candidate

Riga Stradins University

Marketplace (4)

Project cooperation
Novel Antimicrobial Strategies through Host-Directed Therapeutics, Mitochondrial Quality Control and Advanced Infection Models
We seek to join a Horizon Europe consortium developing innovative antimicrobial therapeutics against drug-resistant pathogens.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Author
Tenured Professor at Riga Stradins University
Riga, Latvia
Project cooperation
Deciphering Immune Dysregulation, Herpesvirus Reactivation and Host Susceptibility in Adverse Drug Reactions
We seek to join a clinical and translational consortium investigating the molecular mechanisms, risk factors and personalised prevention of adverse drug reactions associated with polypharmacy.
Consortium/Coordinator seeks Partners
Partner seeks Consortium/Coordinator
Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Author
Tenured Professor at Riga Stradins University
Riga, Latvia
Project cooperation
Functional Immune Biomarkers, Multi-Omics and AI-Driven Precision Medicine for Chronic Diseases
We seek to collaborate with clinical and AI-driven research consortia developing predictive biomarkers for chronic diseases, with particular expertise in post-infectious immune dysfunction and molecular disease heterogeneity.
Consortium/Coordinator seeks Partners
Partner seeks Consortium/Coordinator
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Author
Tenured Professor at Riga Stradins University
Riga, Latvia
Project cooperation
Healthcare Workforce, Critical Care Nursing and Clinical Implementation Partner
Research and clinical implementation partner offering expertise in critical care nursing, healthcare workforce, workload, staffing, patient safety, staff wellbeing, multicentre studies and real-world evaluation of healthcare innovations.
Consortium/Coordinator seeks Partners
Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Author
Clinical Nurse Researcher, Lecturer & PhD Candidate at Riga Stradins University
Riga, Latvia